Clinical Trial Update: Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD) [Phase 2]

View source ↗

Summary

Spinogenix's SPG302 Phase 2 trial in adults with Alzheimer disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• SPG302

Snippet

Sponsor: Spinogenix | Conditions: Alzheimer Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING